JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$15.85
-0.25 (-1.55%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Price Target
Analyst Price Target
+209.8% upside
Low Target
$33.46
Average Target
$49.10
High Target
$61.24
Current Price
$15.85
Current
$15.85
$15.85
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Scenario Analysis
Bear Case
$33.46
111.1%
Low target
Base Case
$49.10
+209.8%
Avg target
Bull Case
$61.24
+286.4%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$35.34
-55.1% from high
52-Week Low
$12.12
+30.8% from low
Target vs 52W High
$49.10
+38.9% vs high
Next Earnings Report
Aug 11, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.39
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |